Mizuho Medy Co.,Ltd.
Mizuho Medy Co., Ltd. 2026 Fiscal Year 12 December Quarter 2 Interim Earnings Report
Interim period of the 2026 fiscal year, 2Q Interim Earnings Report. Discloses trends in revenue and profit, financial position, segment-by-segment status, and revenue breakdown over the last five business years. Also describes sales of COVID-19 related diagnostic tests, product line trends, and cash flow status.
Key Figures
- Revenue: Unknown
- Operating income: Unknown
- Ordinary income: Unknown
AI要約
Overview of results
This interim earnings report indicates trends in revenue and profit, but the amounts are not disclosed in the main text, so they are marked as “Unknown.” The sections describe internet and COVID-19 related diagnostic test sales contributions, utilization trends of various tests, and demand trends in hospital and clinic sectors in each paragraph.
Impact on shareholders and cash flow; future outlook
Includes explanations of cash flow status, the effects of investing and financing activities, and future prospects. Although specific amounts are unknown, the earnings report is structured to present important information clearly.
Mizuho Medy Co., Ltd.
Company overview · Stock price · Financial data · All IR
